Collegium Pharmaceutical (COLL) Short Interest Ratio & Short Volume $33.35 -0.11 (-0.33%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Collegium Pharmaceutical Short Interest DataCollegium Pharmaceutical (COLL) has a short interest of 5.98 million shares, representing 19.22% of the float (the number of shares available for trading by the public). This marks a -0.17% decrease in short interest from the previous month. The short interest ratio (days to cover) is 13.4, indicating that it would take 13.4 days of the average trading volume of 438,964 shares to cover all short positions.Current Short Interest5,980,000 sharesPrevious Short Interest5,990,000 sharesChange Vs. Previous Month-0.17%Dollar Volume Sold Short$171.33 millionShort Interest Ratio13.4 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares32,250,000 sharesFloat Size31,120,000 sharesShort Percent of Float19.22%Today's Trading Volume264,277 sharesAverage Trading Volume438,964 sharesToday's Volume Vs. Average60% Short Selling Collegium Pharmaceutical? Sign up to receive the latest short interest report for Collegium Pharmaceutical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCOLL Short Interest Over TimeCOLL Days to Cover Over TimeCOLL Percentage of Float Shorted Over Time Collegium Pharmaceutical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/20245,980,000 shares $171.33 million -0.2%19.2%13.4 $28.65 12/15/20245,990,000 shares $180.24 million -2.0%19.3%13.6 $30.09 11/30/20246,110,000 shares $186.36 million -2.9%19.6%14.4 $30.50 11/15/20246,290,000 shares $186.06 million +1.3%20.2%15.6 $29.58 10/31/20246,210,000 shares $212.01 million +1.0%19.9%16.7 $34.14 10/15/20246,150,000 shares $236.96 million +3.5%19.7%14.6 $38.53 9/30/20245,940,000 shares $229.52 million -6.5%19.0%13.7 $38.64 9/15/20246,350,000 shares $238.13 million +1.0%20.4%15.1 $37.50 8/31/20246,290,000 shares $241.91 million +3.0%20.1%14.1 $38.46 8/15/20246,110,000 shares $216.78 million -1.8%19.6%12.5 $35.48 Get the Latest News and Ratings for COLL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 7/31/20246,220,000 shares $239.91 million -10.1%19.6%11.4 $38.57 7/15/20246,920,000 shares $219.92 million -0.3%21.8%14.4 $31.78 6/30/20246,940,000 shares $223.47 million +4.7%21.9%14.6 $32.20 6/15/20246,630,000 shares $210.57 million -3.2%20.9%14 $31.76 5/31/20246,850,000 shares $227.01 million -1.2%21.6%14.4 $33.14 5/15/20246,930,000 shares $235.48 million +1.0%21.7%14.7 $33.98 4/30/20246,860,000 shares $253.34 million -1.9%21.8%16.4 $36.93 4/15/20246,990,000 shares $245.63 million -1.8%22.9%17.3 $35.14 3/31/20247,120,000 shares $276.40 million +1.6%23.3%17.5 $38.82 3/15/20247,010,000 shares $274.02 million +4.3%22.9%15.7 $39.09 2/29/20246,720,000 shares $246.69 million -1.5%22.0%15.4 $36.71 2/15/20246,820,000 shares $231.54 million +0.9%22.3%16.1 $33.95 1/31/20246,760,000 shares $222.81 million +6.5%21.4%16.3 $32.96 1/15/20246,350,000 shares $206.44 million -0.5%20.1%15.2 $32.51 12/31/20236,380,000 shares $196.38 million -3.6%20.2%15.9 $30.78 12/15/20236,620,000 shares $196.22 million +0.3%20.9%18.5 $29.64 11/30/20236,600,000 shares $169.16 million -2.9%20.8%21.7 $25.63 11/15/20236,800,000 shares $169.73 million +13.1%21.5%22.9 $24.96 10/31/20236,010,000 shares $130.78 million -7.3%17.8%22.3 $21.76 10/15/20236,480,000 shares $141.91 million +0.2%19.2%21.2 $21.90 9/30/20236,470,000 shares $144.60 million -6.5%19.2%21.8 $22.35 9/15/20236,920,000 shares $156.74 million -6.5%20.5%23.6 $22.65 8/31/20237,400,000 shares $173.31 million -3.1%21.9%23.7 $23.42 8/15/20237,640,000 shares $181.83 million +28.6%22.6%24.6 $23.80 7/31/20235,940,000 shares $135.19 million -9.6%17.6%18.7 $22.76 7/15/20236,570,000 shares $141.98 million -1.5%19.5%21.2 $21.61 6/30/20236,670,000 shares $143.34 million +2.0%19.8%20.2 $21.49 6/15/20236,540,000 shares $144.73 million +4.1%19.4%19.4 $22.13 5/31/20236,280,000 shares $138.60 million -1.3%18.6%19.3 $22.07 5/15/20236,360,000 shares $149.46 million +2.1%19.2%17.7 $23.50DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! 4/30/20236,230,000 shares $144.97 million +0.7%18.7%13.5 $23.27 4/15/20236,190,000 shares $141.94 million +6.2%18.9%13.9 $22.93 3/31/20235,830,000 shares $139.86 million +2.3%17.8%12.6 $23.99 3/15/20235,700,000 shares $134.81 million +4.2%17.4%11.9 $23.65 2/28/20235,470,000 shares $145.12 million +16.1%16.8%11.7 $26.53 2/15/20234,710,000 shares $128.44 million +19.5%14.5%10.8 $27.27 1/31/20233,940,000 shares $110.64 million -0.8%12.2%9.4 $28.08 1/15/20233,970,000 shares $114.06 million +8.5%12.3%13 $28.73 12/30/20223,660,000 shares $84.91 million +2.0%11.3%13 $23.20 12/15/20223,590,000 shares $80.74 million -4.5%11.1%15.8 $22.49 11/30/20223,760,000 shares $82.23 million -4.3%11.6%16.5 $21.87 11/15/20223,930,000 shares $84.61 million +2.3%12.2%17.1 $21.53 10/31/20223,840,000 shares $68.89 million -1.5%11.9%17.3 $17.94 10/15/20223,900,000 shares $69.77 million +2.6%11.9%17.7 $17.89 9/30/20223,800,000 shares $60.88 million +3.0%11.6%16.5 $16.02 9/15/20223,690,000 shares $66.75 million +1.9%11.3%14.4 $18.09 8/31/20223,620,000 shares $63.64 million -1.9%11.1%13.8 $17.58 8/15/20223,690,000 shares $69.34 million +3.4%11.3%13.3 $18.79 7/31/20223,570,000 shares $61.37 million +1.4%11.0%11.3 $17.19 7/15/20223,520,000 shares $58.19 million -2.5%10.8%10.5 $16.53 6/30/20223,610,000 shares $63.97 million -2.7%11.1%10.1 $17.72 6/15/20223,710,000 shares $59.81 million +7.2%11.4%9.9 $16.12 5/31/20223,460,000 shares $54.05 million +4.2%10.6%9.7 $15.62 5/15/20223,320,000 shares $51.92 million No Change10.2%8.2 $15.64 4/30/20223,320,000 shares $53.45 million -0.9%10.2%7.6 $16.10 4/15/20223,350,000 shares $64.25 million -2.1%10.3%8.1 $19.18 3/31/20223,420,000 shares $69.63 million -0.3%10.6%9 $20.36 3/15/20223,430,000 shares $62.22 million -5.3%10.7%10.1 $18.14 2/28/20223,620,000 shares $70.48 million +4.6%11.3%10.4 $19.47 2/15/20223,460,000 shares $75.50 million +4.5%10.4%10.6 $21.82 1/31/20223,310,000 shares $59.08 million -2.4%9.9%13 $17.85 1/15/20223,390,000 shares $62.85 million -2.0%10.1%11.8 $18.54 12/31/20213,460,000 shares $64.63 million -5.7%10.3%12.3 $18.68 12/15/20213,670,000 shares $68.45 million -15.4%11.0%12.6 $18.65 11/30/20214,340,000 shares $76.30 million -9.6%12.9%15.7 $17.58 11/15/20214,800,000 shares $96.05 million +24.7%14.3%17.8 $20.01 10/29/20213,850,000 shares $75.58 million +2.7%11.5%13 $19.63 10/15/20213,750,000 shares $78.68 million +1.1%10.9%13.2 $20.98 9/30/20213,710,000 shares $73.24 million +2.5%10.8%12.5 $19.74 9/15/20213,620,000 shares $71.89 million +6.8%10.5%12 $19.86 8/31/20213,390,000 shares $69.60 million -6.4%9.8%11.4 $20.53 8/13/20213,620,000 shares $64.26 million -12.1%10.5%11.9 $17.75 7/30/20214,120,000 shares $102.55 million -3.3%12.0%15 $24.89 7/15/20214,260,000 shares $100.20 million +1.7%12.5%17.2 $23.52 6/30/20214,190,000 shares $99.05 million -3.2%12.2%17.7 $23.64 6/15/20214,330,000 shares $99.37 million +7.2%12.6%17.3 $22.95 5/28/20214,040,000 shares $96.52 million -3.1%11.8%15.6 $23.89 5/14/20214,170,000 shares $90.66 million -3.9%N/A13.7 $21.74 4/30/20214,340,000 shares $96.57 million +0.7%N/A8.2 $22.25 4/15/20214,310,000 shares $103.53 million +1.4%N/A7.8 $24.02DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! 3/31/20214,250,000 shares $101.32 million No Change13.0%7.3 $23.84 3/15/20214,250,000 shares $108.12 million -6.2%13.0%7.1 $25.44 2/26/20214,530,000 shares $117.92 million +8.9%13.9%7.8 $26.03 2/12/20214,160,000 shares $104.50 million -2.1%12.8%7.7 $25.12 1/29/20214,250,000 shares $104.55 million +2.7%13.1%11.7 $24.60 1/15/20214,140,000 shares $92.28 million +6.4%12.8%13.4 $22.29 12/31/20203,890,000 shares $77.49 million -0.8%11.9%13.9 $19.92 12/15/20203,920,000 shares $73.15 million -3.0%12.0%14.9 $18.66 11/30/20204,040,000 shares $77.53 million -14.8%12.3%15 $19.19 11/15/20204,740,000 shares $90.91 million +11.8%14.5%15.7 $19.18 10/30/20204,240,000 shares $76.49 million -4.5%12.9%14.1 $18.04 10/15/20204,440,000 shares $94.13 million +1.4%13.6%13.2 $21.20 9/30/20204,380,000 shares $91.19 million +3.8%13.4%12.5 $20.82 9/15/20204,220,000 shares $80.26 million +2.9%12.9%11.8 $19.02 8/31/20204,100,000 shares $78.15 million +3.3%12.5%10.7 $19.06 8/14/20203,970,000 shares $72.10 million -5.0%12.1%9.7 $18.16 7/31/20204,180,000 shares $65.96 million -3.9%13.0%9.4 $15.78 7/15/20204,350,000 shares $75.52 million -7.1%13.6%10.4 $17.36 6/30/20204,680,000 shares $80.22 million -6.8%14.7%10.3 $17.14 6/15/20205,020,000 shares $88.35 million +13.3%15.8%11 $17.60 5/29/20204,430,000 shares $97.68 million -3.5%13.9%8.7 $22.05 5/15/20204,590,000 shares $101.12 million -6.9%14.3%8.4 $22.03 4/30/20204,930,000 shares $101.66 million +2.9%15.7%6.6 $20.62 4/15/20204,790,000 shares $93.55 million +3.0%15.2%6.6 $19.53 3/31/20204,650,000 shares $95.60 million -16.7%15.0%6.5 $20.56 3/13/20205,582,500 shares $107.74 million +8.4%18.2%8.3 $19.30 2/28/20205,150,000 shares $71.59 million +17.3%16.8%8.1 $13.90 2/14/20204,390,000 shares $87.14 million +82.2%14.5%7.5 $19.85 1/31/20202,410,000 shares $54.39 million +4.3%8.3%4.7 $22.57 COLL Short Interest - Frequently Asked Questions What is Collegium Pharmaceutical's current short interest? Short interest is the volume of Collegium Pharmaceutical shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 5,980,000 shares of COLL short. 19.22% of Collegium Pharmaceutical's shares are currently sold short. Learn More on Collegium Pharmaceutical's current short interest. What is a good short interest ratio for Collegium Pharmaceutical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. COLL shares currently have a short interest ratio of 13.0. Learn More on Collegium Pharmaceutical's short interest ratio. Which institutional investors are shorting Collegium Pharmaceutical? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Collegium Pharmaceutical: Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Collegium Pharmaceutical? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 19.22% of Collegium Pharmaceutical's floating shares are currently sold short. Is Collegium Pharmaceutical's short interest increasing or decreasing? Collegium Pharmaceutical saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 5,980,000 shares, a decline of 0.2% from the previous total of 5,990,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Collegium Pharmaceutical's float size? Collegium Pharmaceutical currently has issued a total of 32,250,000 shares. Some of Collegium Pharmaceutical's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Collegium Pharmaceutical currently has a public float of 31,120,000 shares. How does Collegium Pharmaceutical's short interest compare to its competitors? 19.22% of Collegium Pharmaceutical's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Collegium Pharmaceutical: Viking Therapeutics, Inc. (17.47%), Axsome Therapeutics, Inc. (13.66%), Krystal Biotech, Inc. (11.72%), TG Therapeutics, Inc. (18.50%), Organon & Co. (7.14%), Scholar Rock Holding Co. (16.41%), Alvotech (0.40%), Ultragenyx Pharmaceutical Inc. (4.35%), ADMA Biologics, Inc. (5.76%), Biohaven Ltd. (9.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Collegium Pharmaceutical stock? Short selling COLL is an investing strategy that aims to generate trading profit from Collegium Pharmaceutical as its price is falling. COLL shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Collegium Pharmaceutical? A short squeeze for Collegium Pharmaceutical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of COLL, which in turn drives the price of the stock up even further. How often is Collegium Pharmaceutical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including COLL, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies VKTX Short Interest AXSM Short Interest KRYS Short Interest TGTX Short Interest OGN Short Interest SRRK Short Interest ALVO Short Interest RARE Short Interest ADMA Short Interest BHVN Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:COLL) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Collegium Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
